Cullen/Frost Bankers’s Artivion AORT Stock Holding History

Cullen/Frost Bankers’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-536	Closed	-$9.21K	–	1154
2023 Q2	$9.21K	Hold	536	–	–	﹤0.01%	929
2023 Q1	$7.02K	Hold	536	–	–	﹤0.01%	990
2022 Q4	$6.5K	Hold	536	–	–	﹤0.01%	955
2022 Q3	$7K	Hold	536	–	–	﹤0.01%	963
2022 Q2	$10K	Buy	+536	New	+$10.3K	﹤0.01%	910

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Cullen/Frost Bankers's AORT Position: Q3 2023 in Review

Cullen/Frost Bankers sold out of Artivion (AORT) in Q3 2023, closing a stake of 536 shares — an estimated $9.21K sold.

Cullen/Frost Bankers first reported a position in AORT in Q2 2022 and held it in 5 quarters. The position peaked at $10K in Q2 2022. 142 funds tracked by Wall St. Rank hold AORT as of Q3 2023.

Cullen/Frost Bankers reported no remaining Artivion position as of Q3 2023 after selling out during the quarter.
Cullen/Frost Bankers sold 536 Artivion shares in Q3 2023, an estimated $9.21K.
Cullen/Frost Bankers first reported a position in Artivion in Q2 2022 and held it in 5 quarters.
Cullen/Frost Bankers's Artivion position peaked at $10K in Q2 2022.
142 funds tracked by Wall St. Rank held Artivion as of Q3 2023.

Based on Cullen/Frost Bankers's 13F filing for Q3 2023, filed 2 Nov 2023.